MIRA - MIRA Pharmaceuticals, Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
1.46 0.04 (2.74%) --- --- 0.0 (0.0%) 0.04 (2.74%) -0.01 (-0.65%) -0.07 (-4.61%) -0.02 (-1.32%)

Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: PreMarket

Earnings & Ratios

Basic EPS:
-0.09
Diluted EPS:
-0.09
Basic P/E:
-16.6667
Diluted P/E:
-16.6667
RSI(14) 1m:
100.0
VWAP:
1.5
RVol:
0.0033

Events

Period Kind Movement Occurred At

Related News